Beam Therapeutics BEAM 深 沪
等待开盘 08-13 09:30:00 美东时间
16.86
-0.305
-1.78%
华盛通- 最 高17.63
- 今 开17.35
- 成交量 279.22万股
- 最 低 16.65
- 昨 收 17.165
- 总市值 17.03亿
- 52周最高 35.25
- 市盈率 静 --
- 换手率 2.76%
- 52周最低 13.525
- 委 比 84.83%
- 总股本 1.01亿
- 历史最高 138.522
- 量 比 1.20
- 振 幅 5.71%
- 历史最低 13.00
- 每 手 1
- 风险率 4.18%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Beam Global to Release Q2 2025 Operating Results, Conference Call Scheduled for August 14, 2025 at 4:30 p.m. ET
Beam Global will report Q2 2025 results on August 14, 2025 after market close. A conference call at 4:30 p.m. ET will discuss financials and updates. Pre-registration required via provided link._call sterng:Beam Global to release Q2 2025 results on August 14, 2025, followed by a conference call at 4:30 p.m. ET. Pre-register through the link for access.
08-11 10:00
Beam Therapeutics Reports Second Quarter 2025 Financial Results and Provides Update on BEAM-302 Development Progress in Alpha-1 Antitrypsin Deficiency (AATD)
<p>Beam Therapeutics reported第二季度2025财务结果，BEAM-302治疗α-1抗胰蛋白酶缺乏症的临床进展更新，BEAM-101用于镰状细胞病的研究进展。第二季度结束时，公司拥有12亿美元的现金储备，预计支持运营至2028年。BEAM-302在17名患者中显示耐受性良好，BEAM-101已治疗30名镰状细胞病患者。公司计划在2026年初公布BEAM-302的进一步数据，并在年底分享BEACON试验的最新信息。</p>
08-05 11:00
Infibeam Avenues Transfers Equity Shares to IEPF Authority
Infibeam Avenues Ltd. ( ($IN:INFIBEAM) ) has issued an announcement. Infibeam A...
08-01 13:55
Beam Global Reports 21% ESS Revenue Growth and $2M Order from Major Customer
Beam Global reported a 21% increase in energy storage solutions (ESS) revenue in H1 2025 compared to 2024, along with a $2 million purchase order from a major customer. The growth reflects the company's expanding role as a trusted ESS supplier, driven by repeat orders and new clients, including a Fortune 500 automotive company. Beam Global attributes the momentum to its loyal customer base and increasing global demand for scalable, safe ESS solut...
07-24 10:00
Beam Therapeutics Acquires Early-Stage Life Sciences Firm
Beam Therapeutics ( ($BEAM) ) has provided an update. On July 1, 2025, Beam The...
07-04 05:04
Warren Buffett to donate $6B Berkshire stock to charities
Warren Buffett, CEO of Berkshire Hathaway (NYSE:BRK.B) (NYSE:BRK.A), is set to donate nearly $6B worth of his company shares to five charitable organizations on Monday, with the Bill & Melinda Gates F...
06-28 22:43
Cathie Wood's Ark Invest Continues To Offload Coinbase, Bets Big On SoFi Technologies
Cathie Wood-led Ark Invest made notable trades on Friday, including selling shares in Coinbase and Roblox.
06-28 10:48
FDA细胞与基因治疗监管层集体停职 基因编辑股再遭冲击
智通财经注意到，周五美股盘初，基因编辑公司股价整体持稳，随后随大盘下跌。此前美国FDA生物制品评价与研究中心(CBER)再次突发人事变动——继年初前主任彼得·马...
06-20 21:57
Gene editors steady despite latest leadership shake-up at FDA
Shares of gene editing companies were largely steady in the premarket on Friday after the FDA’s Center for Biologics Research and Evaluation (CBER) faced another abrupt leadership transition following...
06-20 20:39
超93亿！基因治疗企业溢价113%卖出
（转自：动脉新医药） 当地时间2025年 6月17日，礼来正式宣布收购总部位于波士顿的临床阶段公司 Verve Therapeutics，Inc.（纳斯达克代码...
06-18 17:00
